USE OF RENIN-ANGIOTENSIN ANTAGONIST FOR REDUCING POST MYOCARDIAL INFARCT MORBIDITY AND MORTALITY

摘要

2117782 9320839 PCTABS00027 The invention involves a method for treating a human survivor of a heart attack and provides further improvement in survival following the heart attack by the early initiation and long-term administration of a renin-angiotensin system inhibitor, preferably an angiotensin converting enzyme inhibitor. The inhibitor may be used on its own, or in conjuction with other therapeutic compounds such as .beta. blockers and thrombolytic agents. The preferred inhibitor is captopril.